A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder

被引:2
|
作者
Celik, Muhammet [1 ]
Gold, Mark S. [2 ]
Fuehrlein, Brian [3 ,4 ]
机构
[1] New York Med Coll, St Josephs Reg Med Ctr, Yonkers, NY 10705 USA
[2] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63130 USA
[3] VA Connecticut Healthcare Syst, Mental Hlth Serv Line, West Haven, CT 06516 USA
[4] Yale Sch Med, Dept Psychiat, New Haven, CT 06511 USA
关键词
alcohol; alcohol use disorder (AUD); withdrawal; WITHDRAWAL SYNDROME; DOUBLE-BLIND; PHARMACOLOGICAL MANAGEMENT; CONTINGENCY MANAGEMENT; SODIUM OXYBATE; DEPENDENCE; METAANALYSIS; ABUSE; ONDANSETRON; CONSUMPTION;
D O I
10.3390/brainsci14030294
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alcohol use disorder (AUD) is a significant contributor to morbidity and mortality in the United States. It contributes to over 140,000 annual deaths, to over 200 related diseases and health conditions globally, and accounts for 5.1% of the global disease burden. Despite its substantial impact, AUD remains undertreated, marked by a scarcity of approved medications. This paper explores the current treatment landscape and novel strategies for both alcohol withdrawal syndrome and AUD. Promising results, including the use of psychedelics alongside psychotherapy, noninvasive neural-circuit-based interventions, phosphodiesterase-4 inhibitors, and GLP-1 receptor agonists, have emerged from recent studies. While these advancements show potential, further research is crucial for a comprehensive understanding of their effectiveness. The clear shortage of approved medications and other treatment modalities underscores the pressing need for ongoing research.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] Oxytocin as a Treatment for Alcohol Use Disorder and Heavy Drinking: A Narrative Review
    Rastogi, Kriti
    Weerts, Elise M.
    Ellis, Jennifer D.
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2024, 32 (06) : 625 - 638
  • [2] Pharmacotherapy for Alcohol Use Disorder: Current and Emerging Therapies
    Swift, Robert M.
    Aston, Elizabeth R.
    HARVARD REVIEW OF PSYCHIATRY, 2015, 23 (02) : 122 - 133
  • [3] Medications for treating alcohol use disorder: A narrative review
    Kranzler, Henry R.
    Hartwell, Emily E.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 (07): : 1224 - 1237
  • [4] Current trends in the role of neuroinflammation & α-synuclein in alcohol use disorder: A systematic quantitative literature review
    James, Brandon C.
    Cox, Amanda J.
    Lewohl, Joanne M.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 48 (07): : 1209 - 1220
  • [5] Revisiting Baby Boomers and Alcohol Use: Emerging Treatment Trends
    Babatunde, Oyinlola T.
    Outlaw, Kimberly R.
    Forbes, Braden
    Gay, Tameika
    JOURNAL OF HUMAN BEHAVIOR IN THE SOCIAL ENVIRONMENT, 2014, 24 (05) : 597 - 611
  • [6] Ketamine in Substance Use Disorder Treatment: A Narrative Review
    Famula, Anna
    Radoszewski, Jakub
    Czerwiec, Tomasz
    Sobis, Jaroslaw
    Wieckiewicz, Gniewko
    ALPHA PSYCHIATRY, 2024, 25 (02):
  • [7] Alcohol Use Disorder in the Age of Technology: A Review of Wearable Biosensors in Alcohol Use Disorder Treatment
    Davis-Martin, Rachel E.
    Alessi, Sheila M.
    Boudreaux, Edwin D.
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [8] Topiramate Pharmacotherapy for Alcohol Use Disorder and Other Addictions: A Narrative Review
    Manhapra, Ajay
    Chakraborty, Anirban
    Arias, Albert J.
    JOURNAL OF ADDICTION MEDICINE, 2019, 13 (01) : 7 - 22
  • [9] Thiamine Substitution in Alcohol Use Disorder: A Narrative Review of Medical Guidelines
    Pruckner, Nathalie
    Baumgartner, Josef
    Hinterbuchinger, Barbara
    Glahn, Alexander
    Vyssoki, Sandra
    Vyssoki, Benjamin
    EUROPEAN ADDICTION RESEARCH, 2019, 25 (03) : 103 - 110
  • [10] Species differences in comorbid alcohol use disorder and major depressive disorder: A narrative review
    Winkler, Garrett A.
    Grahame, Nicholas J.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2025,